4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-025572
Chief Executive Officer sold 3,000 shares at $58.62 ($175,860)
- Chief Executive Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-04-03 | Option exercise | +3,000 | $0.30 | $908 | 3,000 | D: show line 1 in the form |
| Schenkein David P Chief Executive Officer | 2017-04-03 | Sale | −3,000 | $58.62 | $175,860 | 0 | D: show line 2 in the form |
| Open-market sales · 3,000 sh · avg $58.62 · $175,860 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-04-03 | Option exercise · Stock option (right to buy) | −3,000 | 195,656 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…